Julie Hartenstein, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5719 Widewaters Pkwy, De Witt, NY 13214 Phone: 315-449-1301 Fax: 315-449-2707 |
Vincent Marino Jr., P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5719 Widewaters Pkwy, De Witt, NY 13214 Phone: 315-449-1301 Fax: 315-449-2707 |
Ms. Danielle Lynn Motyka, MSPT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 224 Wellington Rd, De Witt, NY 13214 Phone: 315-449-4670 |
Jill A Spinoso, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 5719 Widewaters Pkwy, De Witt, NY 13214 Phone: 315-449-1301 Fax: 315-449-2707 |
Katie Curran Iv, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5719 Widewaters Pkwy, De Witt, NY 13214 Phone: 315-449-1301 Fax: 315-449-2707 |
Noah Brown, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5719 Widewaters Pkwy, De Witt, NY 13214 Phone: 315-449-1301 Fax: 315-449-2707 |
Mrs. Catherine Ann Keough, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3218 Erie Blvd E, De Witt, NY 13214 Phone: 315-450-4898 |
Wendy Decker, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5719 Widewaters Pkwy, De Witt, NY 13214 Phone: 315-449-1301 Fax: 315-449-2707 |
Fitness Forum Physical And Occupational Therapy, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5719 Widewaters Pkwy, De Witt, NY 13214 Phone: 315-478-0380 Fax: 315-478-0388 |
News Archive
The mental health of Tolkien's character Gollum has long been a mystery to Lord of the Rings fans, who have argued the nature of Gollum's ‘mental illness' on over 1300 websites –did he have schizophrenia or was he suffering from multiple personality disorder? UCL scientists now diagnose the famous character in a paper published in this week's British Medical Journal (BMJ).
Codexis, Inc. today announced a licensing agreement with Teva Pharmaceutical Industries Ltd., to produce an important publicly-undisclosed generic product, using a proprietary Codexis biocatalyst.
Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.
BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) announces that its subsidiary BioSyent Pharma Inc. has signed an exclusive product development, supply and distribution agreement with a new partner for a new product under its Hospital Products Division.
Although doctors for years have "talked about the health effects of hormones on bones, breasts and women's hearts," diabetes has not been "part of the debate" until last week, when the North American Menopause Society in a revised position statement said that women taking hormone replacement therapy appear to be less likely to develop the disease, the Wall Street Journal reports.
› Verified 9 days ago